| Unmatched | Matched | ||||
---|---|---|---|---|---|---|
Low CRP(n = 711) | High CRP(n = 250) | P-value | Low CRP(n = 176) | High CRP(n = 176) | P-value | |
Gender | ||||||
 Male | 546 (76.7%) | 203 (81.2%) | 0.137 | 136 (77.3%) | 141 (80.1%) | 0.517 |
 Female | 165 (23.3%) | 47 (18.8%) |  | 40 (22.7%) | 35 (19.9%) | |
Age, y | 58 (49,65) | 60 (50,70) | 0.001 | 60 (57–63) | 60 (57–63) | 0.735 |
Smoking | ||||||
 Yes | 455 (64%) | 173 (69.2%) | 0.137 | 112 (63.6%) | 121 (68.7%) | 0.312 |
 No | 256 (36%) | 77 (30.8%) |  | 64 (36.4%) | 55 (31.3%) | |
Drinking | ||||||
 Yes | 238 (33.5%) | 95 (38.2%) | 0.182 | 62 (35.2%) | 70 (39.4%) | 0.417 |
 No | 473 (66.5%) | 155 (61.8%) |  | 114 (64.8%) | 106 (60.6%) | |
Tumor site | ||||||
 Cervix | 17 (2.4%) | 1 (0.4%) |  | 6 (3.4%) | 1 (0.6%) | 0.777 |
 Up | 104 (14,6%) | 40 (16.0%) | 0.635 | 22 (12.5%) | 31 (17.7%) | |
 Middle | 350 (49.3%) | 123 (49.2%) |  | 94 (53.4%) | 83 (47.4%) | |
 Low | 240 (33.7%) | 86 (34.4%) |  | 54 (30.7%) | 60 (34.2%) | |
TNM stage | ||||||
 IA | 6 (0.8%) | 3 (1.2%) |  | 3 (1.7%) | 0 | 0.970 |
 IB | 94 (13.2%) | 17 (6.8%) |  | 13 (7.4%) | 18 (10.2%) | |
 IIA | 117 (16.5%) | 44 (17.6%) | 0.254 | 30 (17.0%) | 32 (18.2%) | |
 IIB | 194 (27.3%) | 69 (27.6%) |  | 44 (25.0) | 42 (23.9%) | |
 IIIA | 158 (22.2%) | 68 (27.2%) |  | 47 (26.7%) | 44 (25.0%) | |
 IIIB | 83 (11.7%) | 35 (14%) |  | 26 (14.8%) | 23 (13.1%) | |
 IIIC | 59 (8.3%) | 14 (5.6%) |  | 13 (7.4%) | 17 (9.7%) | |
Differentiation | ||||||
 Well | 192 (27%) | 86 (34.4%) |  | 57 (32.4%) | 63 (35.3%) | 0.823 |
 Moderate | 404 (56.8%) | 120 (48.0%) | 0.086 | 85 (48.3%) | 78 (44.3%) | |
 Poor | 115 (16.2%) | 44 (17.6%) |  | 34 (19.3%) | 36 (20.5%) | |
Surgical incision | ||||||
 Left | 434 (61.0%) | 165 (66.0%) | 0.176 | 105 (59.7%) | 117 (66.5%) | 0.199 |
 Right | 277 (39.0%) | 85 (34.0%) |  | 71 (40.3%) | 59 (33.5%) |